N-(5-Bromo[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide, 97%, 10g

Ácido 2-fosfobutano-1,2,4-tricarboxílico (PBTC), mínimo 47 %, 100 ml, envase de vidrio

(S)-2-((tert-Butoxycarbonyl)amino)-3-(3,4-dichlorophenyl)propanoic acid, 95.0%, 1g

tert-Butyl (R)-4,5-diamino-5-oxopentanoate hydrochloride, 97%, 100g

N-(4-Bromo-3,5-difluorophenyl)acetamide, 95.0%, 1g

1-Butene (ca. 10% in Hexane)500mL

N-[3-(1H-imidazol-1-yl)propyl]-5,7-dimethyl-1,3-benzothiazol-2-amine, 95.0%, 500mg

3-Iodotoluene>98.0%(GC)500g

LRRK2-IN-1, 95%, 250mg

(S)-3-Amino-2-phenylpropanoic acid, 95.0%, 100mg

3,5-Dimethoxyphenol, 98.0%, 25g

5,7-Dihydroxy-2H-chromen-2-one, 95.0%, 5g

2-Bromo-4,5-dimethylpyridine, 97%, 5g